Crispr Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $150M | 2.8M | 54.01 |
| 2024-03-31 | $174M | 2.5M | 68.16 |
| 2023-09-30 | $123M | 2.7M | 45.39 |
| 2023-06-30 | $153M | 2.7M | 56.14 |
| 2023-03-31 | $127M | 2.8M | 45.23 |
| 2022-12-31 | $107M | 2.6M | 40.65 |
| 2022-06-30 | $131M | 2.2M | 60.77 |
| 2021-06-30 | $170M | 1.1M | 161.86 |
| 2021-03-31 | $157M | 1.3M | 121.84 |
| 2020-12-31 | $180M | 1.2M | 153.14 |
| 2020-09-30 | $97M | 1.2M | 83.60 |
| 2020-03-31 | $26M | 614k | 41.96 |
| 2019-12-31 | $40M | 629k | 62.94 |
| 2019-09-30 | $26M | 616k | 41.96 |
| 2019-06-30 | $29M | 595k | 48.95 |
| 2019-03-31 | $21M | 601k | 35.72 |
| 2018-12-31 | $18M | 639k | 28.57 |
| 2018-09-30 | $29M | 710k | 41.24 |
| 2018-06-30 | $37M | 594k | 61.86 |
| 2018-03-31 | $26M | 572k | 45.71 |
| 2017-09-30 | $59k | 3.3k | 17.86 |